Go to content
UR Home

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Heinzelmann, F. ; Bethge, W. ; Beelen, D. W. ; Engelhard, M. ; Kröger, N. ; Dreger, P. ; Niederwieser, D. ; Finke, J. ; Bunjes, D. ; Tischer, J. ; Kobbe, G. ; Holler, E. ; Bornhäuser, M. ; Stelljes, M. ; Baurmann, H. ; Müller, A. ; Haubitz, I. ; Schrezenmeier, H. ; Müller, C. ; Ottinger, H.


Allogeneic hematopoietic cell transplantation (HCT) offers the chance of cure for patients with non-transformed follicular lymphoma (FL), but is associated with the risk of non-relapse mortality (NRM). The aim of this study was to identify subgroups of FL patients who benefit from HCT. The European Society for Blood and Marrow Transplantation (EBMT) Minimum-Essential-A Data of 146 consecutive ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons